Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
Authors
Keywords
Castration-resistant prostate cancer (CRPC), Androgen receptor (AR), AR-V7, NUP210, SLC3A2
Journal
Translational Oncology
Volume 14, Issue 1, Pages 100915
Publisher
Elsevier BV
Online
2020-10-21
DOI
10.1016/j.tranon.2020.100915
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks
- (2019) Anna A. Igolkina et al. Cells
- The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
- (2018) Rokaya El Ansari et al. BRITISH JOURNAL OF CANCER
- The potential of AR-V7 as a therapeutic target
- (2018) Takuma Uo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis
- (2018) Joana Borlido et al. NATURE IMMUNOLOGY
- Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
- (2018) Veronica Rodriguez-Bravo et al. CELL
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells
- (2017) Keisuke Matsusaka et al. JOURNAL OF PATHOLOGY
- SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway
- (2017) Bin Zhu et al. ONCOLOGY REPORTS
- Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
- (2017) Atsushi Okabe et al. Scientific Reports
- Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells
- (2016) Minhui Xu et al. JOURNAL OF UROLOGY
- Extracellular Release of Annexin A2 is Enhanced upon Oxidative Stress Response via the p38 MAPK Pathway after Low-Dose X-Ray Irradiation
- (2016) Kazuko Kita et al. RADIATION RESEARCH
- TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection
- (2016) Hiroe Namba-Fukuyo et al. Oncotarget
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
- (2015) Benjamin L. Maughan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Nuclear pore proteins and the control of genome functions
- (2015) Arkaitz Ibarra et al. GENES & DEVELOPMENT
- The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells
- (2015) Ji Lu et al. JOURNAL OF UROLOGY
- Are androgen receptor variants a substitute for the full-length receptor?
- (2015) Ji Lu et al. Nature Reviews Urology
- CD98hc (SLC3A2) Loss Protects Against Ras-Driven Tumorigenesis by Modulating Integrin-Mediated Mechanotransduction
- (2014) S. Estrach et al. CANCER RESEARCH
- CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
- (2013) Marina Poettler et al. Molecular Cancer
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
- (2012) Siu Chiu Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- The Structure of the Nuclear Pore Complex
- (2011) André Hoelz et al. Annual Review of Biochemistry
- Identification and validation of genes involved in cervical tumourigenesis
- (2011) Thangarajan Rajkumar et al. BMC CANCER
- Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence
- (2011) Atsushi Kaneda et al. PLoS Genetics
- GREAT improves functional interpretation of cis-regulatory regions
- (2010) Cory Y McLean et al. NATURE BIOTECHNOLOGY
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started